# Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Intoxication

> **NCT05715723** · — · COMPLETED · sponsor: **POLYSAN Scientific & Technological Pharmaceutical Company** · enrollment: 296 (actual)

## Conditions studied

- Ethanol Intoxication

## Interventions

- **DRUG:** Reamberin

## Key facts

- **NCT ID:** NCT05715723
- **Lead sponsor:** POLYSAN Scientific & Technological Pharmaceutical Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-15
- **Primary completion:** 2024-11-01
- **Final completion:** 2025-02-28
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2025-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05715723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05715723, "Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Intoxication". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05715723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*